581 related articles for article (PubMed ID: 32784290)
1. COVID-19 severity associates with pulmonary redistribution of CD1c+ DCs and inflammatory transitional and nonclassical monocytes.
Sánchez-Cerrillo I; Landete P; Aldave B; Sánchez-Alonso S; Sánchez-Azofra A; Marcos-Jiménez A; Ávalos E; Alcaraz-Serna A; de Los Santos I; Mateu-Albero T; Esparcia L; López-Sanz C; Martínez-Fleta P; Gabrie L; Del Campo Guerola L; de la Fuente H; Calzada MJ; González-Álvaro I; Alfranca A; Sánchez-Madrid F; Muñoz-Calleja C; Soriano JB; Ancochea J; Martín-Gayo E;
J Clin Invest; 2020 Dec; 130(12):6290-6300. PubMed ID: 32784290
[TBL] [Abstract][Full Text] [Related]
2. Differential Redistribution of Activated Monocyte and Dendritic Cell Subsets to the Lung Associates with Severity of COVID-19.
Sanchez-Cerrillo I; Landete P; Aldave B; Sanchez-Alonso S; Sanchez-Azofra A; Marcos-Jimenez A; Avalos E; Alcaraz-Serna A; de Los Santos I; Mateu-Albero T; Esparcia L; Lopez-Sanz C; Martinez-Fleta P; Gabrie L; Del Campo Guerola L; Calzada MJ; Gonzalez-Alvaro I; Alfranca A; Sanchez-Madrid F; Munoz-Calleja C; Soriano JB; Ancochea J; Martin-Gayo E
medRxiv; 2020 May; ():. PubMed ID: 32511573
[TBL] [Abstract][Full Text] [Related]
3. Increased sCD163 and sCD14 Plasmatic Levels and Depletion of Peripheral Blood Pro-Inflammatory Monocytes, Myeloid and Plasmacytoid Dendritic Cells in Patients With Severe COVID-19 Pneumonia.
Zingaropoli MA; Nijhawan P; Carraro A; Pasculli P; Zuccalà P; Perri V; Marocco R; Kertusha B; Siccardi G; Del Borgo C; Curtolo A; Ajassa C; Iannetta M; Ciardi MR; Mastroianni CM; Lichtner M
Front Immunol; 2021; 12():627548. PubMed ID: 33777012
[TBL] [Abstract][Full Text] [Related]
4. Upregulation of CCR4 in activated CD8
Spoerl S; Kremer AN; Aigner M; Eisenhauer N; Koch P; Meretuk L; Löffler P; Tenbusch M; Maier C; Überla K; Heinzerling L; Frey B; Lutzny-Geier G; Winkler TH; Krönke G; Vetter M; Bruns H; Neurath MF; Mackensen A; Kremer AE; Völkl S
Eur J Immunol; 2021 Jun; 51(6):1436-1448. PubMed ID: 33784417
[TBL] [Abstract][Full Text] [Related]
5. Acute SARS-CoV-2 Infection Impairs Dendritic Cell and T Cell Responses.
Zhou R; To KK; Wong YC; Liu L; Zhou B; Li X; Huang H; Mo Y; Luk TY; Lau TT; Yeung P; Chan WM; Wu AK; Lung KC; Tsang OT; Leung WS; Hung IF; Yuen KY; Chen Z
Immunity; 2020 Oct; 53(4):864-877.e5. PubMed ID: 32791036
[TBL] [Abstract][Full Text] [Related]
6. Monocytes and Macrophages, Targets of Severe Acute Respiratory Syndrome Coronavirus 2: The Clue for Coronavirus Disease 2019 Immunoparalysis.
Boumaza A; Gay L; Mezouar S; Bestion E; Diallo AB; Michel M; Desnues B; Raoult D; La Scola B; Halfon P; Vitte J; Olive D; Mege JL
J Infect Dis; 2021 Aug; 224(3):395-406. PubMed ID: 33493287
[TBL] [Abstract][Full Text] [Related]
7. Compartmental immunophenotyping in COVID-19 ARDS: A case series.
Ronit A; Berg RMG; Bay JT; Haugaard AK; Ahlström MG; Burgdorf KS; Ullum H; Rørvig SB; Tjelle K; Foss NB; Benfield T; Marquart HV; Plovsing RR
J Allergy Clin Immunol; 2021 Jan; 147(1):81-91. PubMed ID: 32979342
[TBL] [Abstract][Full Text] [Related]
8. Impaired function and delayed regeneration of dendritic cells in COVID-19.
Winheim E; Rinke L; Lutz K; Reischer A; Leutbecher A; Wolfram L; Rausch L; Kranich J; Wratil PR; Huber JE; Baumjohann D; Rothenfusser S; Schubert B; Hilgendorff A; Hellmuth JC; Scherer C; Muenchhoff M; von Bergwelt-Baildon M; Stark K; Straub T; Brocker T; Keppler OT; Subklewe M; Krug AB
PLoS Pathog; 2021 Oct; 17(10):e1009742. PubMed ID: 34614036
[TBL] [Abstract][Full Text] [Related]
9. SARS-CoV-2 infection induces mixed M1/M2 phenotype in circulating monocytes and alterations in both dendritic cell and monocyte subsets.
Matic S; Popovic S; Djurdjevic P; Todorovic D; Djordjevic N; Mijailovic Z; Sazdanovic P; Milovanovic D; Ruzic Zecevic D; Petrovic M; Sazdanovic M; Zornic N; Vukicevic V; Petrovic I; Matic S; Karic Vukicevic M; Baskic D
PLoS One; 2020; 15(12):e0241097. PubMed ID: 33382687
[TBL] [Abstract][Full Text] [Related]
10. COVID-19-Induced ARDS Is Associated with Decreased Frequency of Activated Memory/Effector T Cells Expressing CD11a
Anft M; Paniskaki K; Blazquez-Navarro A; Doevelaar A; Seibert FS; Hölzer B; Skrzypczyk S; Kohut E; Kurek J; Zapka J; Wehler P; Kaliszczyk S; Bajda S; Thieme CJ; Roch T; Konik MJ; Berger MM; Brenner T; Kölsch U; Meister TL; Pfaender S; Steinmann E; Tempfer C; Watzl C; Dolff S; Dittmer U; Abou-El-Enein M; Westhoff TH; Witzke O; Stervbo U; Babel N
Mol Ther; 2020 Dec; 28(12):2691-2702. PubMed ID: 33186542
[TBL] [Abstract][Full Text] [Related]
11. Lymphocyte Subset Alteration and Monocyte CD4 Expression Reduction in Patients with Severe COVID-19.
Kazancioglu S; Yilmaz FM; Bastug A; Sakallı A; Ozbay BO; Buyuktarakci C; Bodur H; Yilmaz G
Viral Immunol; 2021 Jun; 34(5):342-351. PubMed ID: 33264073
[TBL] [Abstract][Full Text] [Related]
12. A functionally distinct neutrophil landscape in severe COVID-19 reveals opportunities for adjunctive therapies.
Panda R; Castanheira FV; Schlechte JM; Surewaard BG; Shim HB; Zucoloto AZ; Slavikova Z; Yipp BG; Kubes P; McDonald B
JCI Insight; 2022 Jan; 7(2):. PubMed ID: 34908534
[TBL] [Abstract][Full Text] [Related]
13. Cell-Type-Specific Immune Dysregulation in Severely Ill COVID-19 Patients.
Yao C; Bora SA; Parimon T; Zaman T; Friedman OA; Palatinus JA; Surapaneni NS; Matusov YP; Cerro Chiang G; Kassar AG; Patel N; Green CER; Aziz AW; Suri H; Suda J; Lopez AA; Martins GA; Stripp BR; Gharib SA; Goodridge HS; Chen P
Cell Rep; 2021 Jan; 34(1):108590. PubMed ID: 33357411
[TBL] [Abstract][Full Text] [Related]
14. Phenotypical and functional alteration of unconventional T cells in severe COVID-19 patients.
Jouan Y; Guillon A; Gonzalez L; Perez Y; Boisseau C; Ehrmann S; Ferreira M; Daix T; Jeannet R; François B; Dequin PF; Si-Tahar M; Baranek T; Paget C
J Exp Med; 2020 Dec; 217(12):. PubMed ID: 32886755
[TBL] [Abstract][Full Text] [Related]
15. Severe COVID-19 Recovery Is Associated with Timely Acquisition of a Myeloid Cell Immune-Regulatory Phenotype.
Trombetta AC; Farias GB; Gomes AMC; Godinho-Santos A; Rosmaninho P; Conceição CM; Laia J; Santos DF; Almeida ARM; Mota C; Gomes A; Serrano M; Veldhoen M; Sousa AE; Fernandes SM
Front Immunol; 2021; 12():691725. PubMed ID: 34248984
[TBL] [Abstract][Full Text] [Related]
16. Identification of SARS-CoV-2-specific immune alterations in acutely ill patients.
Rébillard RM; Charabati M; Grasmuck C; Filali-Mouhim A; Tastet O; Brassard N; Daigneault A; Bourbonnière L; Anand SP; Balthazard R; Beaudoin-Bussières G; Gasser R; Benlarbi M; Moratalla AC; Solorio YC; Boutin M; Farzam-Kia N; Descôteaux-Dinelle J; Fournier AP; Gowing E; Laumaea A; Jamann H; Lahav B; Goyette G; Lemaître F; Mamane VH; Prévost J; Richard J; Thai K; Cailhier JF; Chomont N; Finzi A; Chassé M; Durand M; Arbour N; Kaufmann DE; Prat A; Larochelle C
J Clin Invest; 2021 Apr; 131(8):. PubMed ID: 33635833
[TBL] [Abstract][Full Text] [Related]
17. Disease-duration based comparison of subsets of immune cells in SARS CoV-2 infected patients presenting with mild or severe symptoms identifies prognostic markers for severity.
Kulkarni-Munje A; Palkar S; Shrivastava S; Lalwani S; Mishra AC; Arankalle VA
Immun Inflamm Dis; 2021 Jun; 9(2):419-434. PubMed ID: 33452858
[TBL] [Abstract][Full Text] [Related]
18. Unique immunological profile in patients with COVID-19.
Varchetta S; Mele D; Oliviero B; Mantovani S; Ludovisi S; Cerino A; Bruno R; Castelli A; Mosconi M; Vecchia M; Roda S; Sachs M; Klersy C; Mondelli MU
Cell Mol Immunol; 2021 Mar; 18(3):604-612. PubMed ID: 33060840
[TBL] [Abstract][Full Text] [Related]
19. Prolonged activation of nasal immune cell populations and development of tissue-resident SARS-CoV-2-specific CD8
Roukens AHE; Pothast CR; König M; Huisman W; Dalebout T; Tak T; Azimi S; Kruize Y; Hagedoorn RS; Zlei M; Staal FJT; de Bie FJ; van Dongen JJM; Arbous SM; Zhang JLH; Verheij M; Prins C; van der Does AM; Hiemstra PS; de Vries JJC; Janse JJ; Roestenberg M; Myeni SK; Kikkert M; Yazdanbakhsh M; Heemskerk MHM; Smits HH; Jochems SP; ;
Nat Immunol; 2022 Jan; 23(1):23-32. PubMed ID: 34937933
[TBL] [Abstract][Full Text] [Related]
20. Increased B-cell activity with consumption of activated monocytes in severe COVID-19 patients.
Kos I; Balensiefer B; Lesan V; Kaddu-Mulindwa D; Thurner L; Christofyllakis K; Bittenbring JT; Ahlgrimm M; Seiffert M; Wagenpfeil S; Bewarder Y; Neumann F; Rixecker T; Smola S; Link A; Krawczyk M; Lammert F; Lepper PM; Bals R; Stilgenbauer S; Bewarder M
Eur J Immunol; 2021 Jun; 51(6):1449-1460. PubMed ID: 33788264
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]